Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis
Open Access
- 4 July 2020
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 198, 108135
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- BioMarin Pharmaceutical
This publication has 30 references indexed in Scilit:
- Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosisExperimental Eye Research, 2013
- Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinosesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinosesHuman Mutation, 2011
- A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosisGenes, Brain and Behavior, 2011
- CHARACTERIZATION OF STERILE INTRAOCULAR INFLAMMATORY RESPONSES AFTER INTRAVITREAL BEVACIZUMAB INJECTIONRetina, 2010
- Bilateral intraocular inflammation after intravitreal bevacizumab in Behcet's diseaseEye, 2009
- Acute Intraocular Inflammation after Intravitreous Injections of Bevacizumab for Treatment of Neovascular Age-related Macular DegenerationOphthalmology, 2008
- A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosisMolecular Genetics and Metabolism, 2006
- The dystrophic retina in multisystem disorders: The electroretinogram in neuronal ceroid lipofuscinosesEye, 1998
- PRESERVATION OF RETINAL FUNCTION IN THE RCS RAT BY LASER TREATMENTRetina, 1984